Variant-specific monoclonal and group-specific polyclonal human immunodeficiency virus type 1 neutralizing antibodies raised with synthetic peptides from the gp120 third variable domain.
The third variable (V3) domain of the human immunodeficiency virus type 1 (HIV-1) external membrane glycoprotein gp120 is of crucial importance in eliciting neutralizing antibodies in infected persons. Polyclonal (PAb) and monoclonal (MAb) antibodies directed against selected epitopes in the V3 doma...
Gardado en:
| Publicado en: | J Virol |
|---|---|
| Principais autores: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society for Microbiology (ASM)
1992
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC240953/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1637373/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.66.3.1823-1831.1992 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
